# Washington Trust Bancorp Inc: financial statements, quarterly

WASH · Nasdaq · CIK 737468 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wash.md) · [Financials](/companies/wash/financials.md) · [Filings](/companies/wash/filings.md) · [Insiders](/companies/wash/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wash/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.2](/filings/0000737468-24-000041.md) | [11.1 d](/filings/0000737468-26-000034.md) | [11.4](/filings/0000737468-25-000024.md) | [12.0](/filings/0000737468-25-000036.md) | [12.4](/filings/0000737468-25-000060.md) | [12.4 d](/filings/0000737468-26-000034.md) | [19.4](/filings/0000737468-26-000101.md) | [12.5](/filings/0000737468-26-000114.md) | [12.7](/filings/0000737468-25-000060.md) | [13.2 d](/filings/0000737468-26-000034.md) | [13.1](/filings/0000737468-26-000101.md) | [13.6](/filings/0000737468-26-000114.md) |
| Interest expense | $m | [47.0](/filings/0000737468-24-000041.md) | [51.3 d](/filings/0000737468-24-000012.md) | [53.6](/filings/0000737468-24-000028.md) | [54.4](/filings/0000737468-24-000034.md) | [55.3](/filings/0000737468-24-000041.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.9](/filings/0000737468-24-000041.md) | [(0.8) d](/filings/0000737468-26-000034.md) | [2.8](/filings/0000737468-25-000024.md) | [3.0](/filings/0000737468-25-000036.md) | [2.8](/filings/0000737468-25-000060.md) | [(19.5) d](/filings/0000737468-26-000034.md) | [3.5](/filings/0000737468-26-000101.md) | [3.9](/filings/0000737468-26-000114.md) | [3.1](/filings/0000737468-25-000060.md) | [4.7 d](/filings/0000737468-26-000034.md) | [3.5](/filings/0000737468-26-000101.md) | [4.3](/filings/0000737468-26-000114.md) |
| Net income | $m | [11.2](/filings/0000737468-24-000041.md) | [12.9 d](/filings/0000737468-26-000034.md) | [10.9](/filings/0000737468-25-000024.md) | [10.8](/filings/0000737468-25-000036.md) | [11.0](/filings/0000737468-25-000060.md) | [(60.8) d](/filings/0000737468-26-000034.md) | [12.2](/filings/0000737468-26-000101.md) | [13.2](/filings/0000737468-26-000114.md) | [10.8](/filings/0000737468-25-000060.md) | [16.0 d](/filings/0000737468-26-000034.md) | [12.6](/filings/0000737468-26-000101.md) | [16.0](/filings/0000737468-26-000114.md) |
| Diluted EPS | $ per share | [0.65](/filings/0000737468-24-000041.md) | not reported | [0.64](/filings/0000737468-25-000024.md) | [0.63](/filings/0000737468-25-000036.md) | [0.64](/filings/0000737468-25-000060.md) | not reported | [0.63](/filings/0000737468-26-000101.md) | [0.68](/filings/0000737468-26-000114.md) | [0.56](/filings/0000737468-25-000060.md) | not reported | [0.66](/filings/0000737468-26-000101.md) | [0.83](/filings/0000737468-26-000114.md) |
| Basic EPS | $ per share | [0.65](/filings/0000737468-24-000041.md) | not reported | [0.64](/filings/0000737468-25-000024.md) | [0.63](/filings/0000737468-25-000036.md) | [0.64](/filings/0000737468-25-000060.md) | not reported | [0.63](/filings/0000737468-26-000101.md) | [0.69](/filings/0000737468-26-000114.md) | [0.57](/filings/0000737468-25-000060.md) | not reported | [0.66](/filings/0000737468-26-000101.md) | [0.84](/filings/0000737468-26-000114.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [7,183](/filings/0000737468-24-000041.md) | [7,203](/filings/0000737468-26-000034.md) | [7,249](/filings/0000737468-25-000024.md) | [7,184](/filings/0000737468-25-000036.md) | [7,142](/filings/0000737468-25-000060.md) | [6,931](/filings/0000737468-26-000034.md) | [6,586](/filings/0000737468-26-000101.md) | [6,745](/filings/0000737468-26-000114.md) | [6,718](/filings/0000737468-25-000060.md) | [6,622](/filings/0000737468-26-000114.md) | [6,459](/filings/0000737468-26-000101.md) | [6,548](/filings/0000737468-26-000114.md) |
| Total liabilities | $m | [6,752](/filings/0000737468-23-000050.md) | [6,730](/filings/0000737468-25-000007.md) | [6,782](/filings/0000737468-24-000028.md) | [6,713](/filings/0000737468-24-000034.md) | [6,639](/filings/0000737468-24-000041.md) | [6,431](/filings/0000737468-26-000034.md) | [6,064](/filings/0000737468-25-000024.md) | [6,218](/filings/0000737468-25-000036.md) | [6,185](/filings/0000737468-25-000060.md) | [6,078](/filings/0000737468-26-000114.md) | [5,912](/filings/0000737468-26-000101.md) | [5,994](/filings/0000737468-26-000114.md) |
| Shareholders' equity | $m | [431](/filings/0000737468-24-000041.md) | [473](/filings/0000737468-26-000034.md) | [467](/filings/0000737468-25-000036.md) | [471](/filings/0000737468-25-000060.md) | [502](/filings/0000737468-25-000060.md) | [500](/filings/0000737468-26-000114.md) | [522](/filings/0000737468-26-000114.md) | [528](/filings/0000737468-26-000114.md) | [533](/filings/0000737468-25-000060.md) | [544](/filings/0000737468-26-000114.md) | [547](/filings/0000737468-26-000114.md) | [554](/filings/0000737468-26-000114.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [29.9 d](/filings/0000737468-24-000041.md) | [11.7 d](/filings/0000737468-26-000034.md) | [1.9](/filings/0000737468-25-000024.md) | [11.2 d](/filings/0000737468-25-000036.md) | [25.7 d](/filings/0000737468-25-000060.md) | [18.8 d](/filings/0000737468-26-000034.md) | [8.5](/filings/0000737468-26-000101.md) | [11.3 d](/filings/0000737468-26-000114.md) | [39.6 d](/filings/0000737468-25-000060.md) | [20.9 d](/filings/0000737468-26-000034.md) | [16.1](/filings/0000737468-26-000101.md) | [23.1 d](/filings/0000737468-26-000114.md) |
| Capital expenditure | $m | [0.5](/filings/0000737468-23-000050.md) | [1.5 d](/filings/0000737468-26-000034.md) | [0.6](/filings/0000737468-25-000024.md) | [1.6 d](/filings/0000737468-25-000036.md) | [1.3 d](/filings/0000737468-25-000060.md) | [0.5 d](/filings/0000737468-26-000034.md) | [0.1](/filings/0000737468-26-000101.md) | [0.4 d](/filings/0000737468-26-000114.md) | [0.3 d](/filings/0000737468-25-000060.md) | [1.2 d](/filings/0000737468-26-000034.md) | [1.3](/filings/0000737468-26-000101.md) | [1.1 d](/filings/0000737468-26-000114.md) |
| Dividends paid | $m | [9.6 d](/filings/0000737468-24-000041.md) | [9.6 d](/filings/0000737468-26-000034.md) | [9.5](/filings/0000737468-25-000024.md) | [9.7 d](/filings/0000737468-25-000036.md) | [9.6 d](/filings/0000737468-25-000060.md) | [9.6 d](/filings/0000737468-26-000034.md) | [10.8](/filings/0000737468-26-000101.md) | [11.0 d](/filings/0000737468-26-000114.md) | [10.8 d](/filings/0000737468-25-000060.md) | [10.7 d](/filings/0000737468-26-000034.md) | [10.7](/filings/0000737468-26-000101.md) | [10.9 d](/filings/0000737468-26-000114.md) |
| Share repurchases | $m | [0.0 d](/filings/0000737468-24-000041.md) | [0.1 d](/filings/0000737468-26-000034.md) | [0.0](/filings/0000737468-24-000028.md) | [0.0 d](/filings/0000737468-25-000036.md) | [0.0 d](/filings/0000737468-25-000060.md) | [0.0 d](/filings/0000737468-26-000034.md) | not reported | not reported | [6.4 d](/filings/0000737468-25-000060.md) | [0.6 d](/filings/0000737468-26-000034.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.3](/filings/0000737468-23-000050.md) | [17.2](/filings/0000737468-24-000028.md) | [17.0](/filings/0000737468-24-000034.md) | [17.0](/filings/0000737468-24-000041.md) | [17.1](/filings/0000737468-25-000024.md) | [17.1](/filings/0000737468-25-000036.md) | [17.1](/filings/0000737468-25-000060.md) | [19.4](/filings/0000737468-26-000101.md) | [19.4](/filings/0000737468-26-000114.md) | [19.2](/filings/0000737468-25-000060.md) | [19.2](/filings/0000737468-26-000101.md) | [19.2](/filings/0000737468-26-000114.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,074,321 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000737468-26-000114.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.